Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective binding to ATP sites in protein kinases, making it valuable in targeted therapies for leukemia and other malignancies. Also employed in research for antiviral drug design due to its ability to mimic purine bases. Commonly modified to enhance solubility and bioavailability in pharmaceutical formulations.